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Summary
Genomic imprinting is an epigenetic mechanism of
regulation that restrains the expression of a small sub-
set ofmammalian genes to one parental allele. The rea-
son for the targeting of thesew80 genes by imprinting
remains uncertain. We show that inactivation of the
maternally repressed Zac1 transcription factor results
in intrauterine growth restriction, altered bone forma-
tion, and neonatal lethality. A meta-analysis of micro-
array data reveals thatZac1 is amember of anetwork of
coregulated genes comprising other imprinted genes
involved in the control of embryonic growth. Zac1
alters the expression of several of these imprinted
genes, including Igf2, H19, Cdkn1c, and Dlk1, and it
directly regulates the Igf2/H19 locus through binding
to a shared enhancer. Accordingly, these data identify
a network of imprinted genes, including Zac1, which
controls embryonic growth and which may be the
basis for the implementation of a commonmechanism
of gene regulation during mammalian evolution.
Introduction
Since the discovery of mammalian genomic imprinting
in the mid 1980s (Cattanach and Kirk, 1985; McGrath
and Solter, 1981; Surani et al., 1984), this form of epi-
genetic regulation has been the focus of extensive in-
vestigations (Constancia et al., 2004; Reik and Lewis,
2005). The mechanisms underlying parental origin-
specific expression of several imprinted genes are now
well understood (Delaval and Feil, 2004; Verona et al.,
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V6T 1Z4, Canada.2003). The drive for the selection of genomic imprint-
ing during mammalian evolution was formalized in the
‘‘parental conflict’’ or ‘‘kinship’’ theory (Moore and Haig,
1991; Wilkins and Haig, 2003). Presently, imprinting is
understood as a mechanism aimed at controlling the
amount of maternal resources allocated to the offspring
from conception to weaning (Constancia et al., 2004). In
contrast, fewer studies describe the biological func-
tion(s) carried out by imprinted genes. These genes are
members of various gene families, and the correspond-
ing proteins have diverse biochemical activities (Tycko
and Morison, 2002), indicating that imprinting does not
target a specific biochemical process. Conversely, a
recurrent theme in the biology of imprinted genes is
the control of embryonic development. Alteration of im-
printed loci is consistently associated with developmen-
tal disorders in humans. Moreover, analysis of gain- and
loss-of-function mouse mutants indicates that a number
of imprinted genes are critically involved in the control of
embryonic growth, either directly or by modulating the
transport of nutrients across the placenta. At least two
imprinted genes, Mest/Peg1 and Peg3/Pw1, are addi-
tionally involved in controlling the quality of care that
a mouse mother directs toward her offspring (Lefebvre
et al., 1998; Li et al., 1999), and GnasXL is required for
postnatal adaptation to feeding (Plagge et al., 2004).
The number and identity of imprinted genes involved
in each of these processes, and the underlying gene
networks, remain ill defined at the moment.
Genomic imprinting of mouse Zac1, as well as its hu-
man ortholog ZAC/LOT1/PLAGL1, results in paternal-
specific expression of the gene (Kamiya et al., 2000;
Piras et al., 2000), which encodes a zinc finger transcrip-
tion factor inducing apoptosis and cell-cycle arrest
(Spengler et al., 1997; Varrault et al., 1998). Loss of ZAC
expression is frequently observed in various neoplasms
such as breast tumors (Bilanges et al., 1999), ovary
tumors (Cvetkovic et al., 2004), nonfunctioning pituitary
tumors (Pagotto et al., 2000), head and neck tumors
(Koy et al., 2004), and basal cell carcinomas (Basyuk
et al., 2005). Indeed, a tumor suppressor gene is known
to reside on 6q24-q25, close to the ZAC locus. Further-
more, gain of ZAC function through biallelic expression,
duplication of the paternal allele, or isodisomy of the pa-
ternal chromosome 6 is associated with transient neo-
natal diabetes mellitus (TNDM) (Gardner et al., 2000;
Kamiya et al., 2000), a genetic disease resulting in de-
fective development of the pancreas (Ma et al., 2004).
Because Zac1 displays abundant, albeit regionally re-
stricted, expression during development (Valente and
Auladell, 2001), we sought for a role for this imprinted
gene in the control of embryonic development and inac-
tivated the gene by homologous recombination.
Results
Generation of Zac1-Deficient Mice
To investigate a role for Zac1 during embryonic develop-
ment, we inactivated Zac1 by homologous recombina-
tion in embryonic stem (ES) cells. We targeted the region
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712Figure 1. Targeted Disruption of Zac1 Gene
(A) Structure of the targeting construct and of the mouse wild-type
and knockout alleles. The coding region (black boxes) is within the
two last exons (boxes) of Zac1. A PstI (P)-AvaI (A) genomic fragment
comprising the translation initiation site (ATG) and the entire zinc
finger domain was replaced by a neomycin-resistance cDNA (neo)
under the control of the polymerase II promoter (pPOLII). The trans-
lation termination sites (Stop1, Stop2) resulting from alternative
splicing of the mRNA are indicated (Spengler et al., 1997). A PCR
fragment downstream of the 30 Bgl II (B) restriction site was used
as a 30 probe.
(B) Southern blot analysis of G418- and gancyclovir-resistant ES
clones. Genomic DNA was prepared from the indicated ES clones,
digested with KpnI, run on an agarose gel, blotted to a nylon mem-
brane, and probed with a radioactively labeled 30 probe. Due to the
replacement of a genomic sequence containing a KpnI site by
the neo cassette, the labeled band shifted from 8 kb (wt allele) to
12.8 kb (knockout allele).
(C) The absence of Zac1 protein in knockout animals was verified by
western blotting. Total protein lysates were prepared from wild-type
and Zac12/2 pituitary glands, run on a polyacrylamide gel, blotted
onto a nitrocellulose membrane, and probed with a rabbit antiserum
raised against bacterially produced GST-Zac1 fusion protein. The
wild-type lysate displayed two immunoreactive bands correspond-
ing to the two Zac1 isoforms arising from alternative splicing, as
indicated by bands recognized by the antiserum in lysates from
LLC-PK1 cells transfected with cDNAs encoding each of the iso-
forms. The knockout lysate does not display any immunoreactiveencoding the N-terminal zinc finger domain by deleting
the first and the 50 part of the second coding exons
(Figure 1A). G418- and gancyclovir-resistant clones
were screened for homologous recombination with 30
(Figure 1B) and 50 (data not shown) probes. The absence
of random integration was verified with a Neo probe
(data not shown). The positive clones were microin-
jected into 3.5 day C57BL/6 blastocysts to generate chi-
merical animals. Male chimeras were mated to C57BL/6
females to produce Zac1 heterozygotes. The F1 hetero-
zygotes were backcrossed to C57BL/6 and CBA mice
for more than ten generations, and the study was per-
formed with animals >N10. Intercrosses of Zac1+/2
mice produced Zac1-homozygous null mice. To confirm
the absence of normal Zac1 protein in adult homozy-
gotes, we performed western blot analysis. In the wild-
type pituitary gland, Zac1 antibody detected the two
isoforms of the Zac1 protein arising from alternative
splicing (Spengler et al., 1997), whereas neither isoform
was detected in Zac12/2 homozygous pituitary glands
(Figure 1C). Consistent with complete maternal silenc-
ing, no Zac1 transcripts could be detected in E18.5
Zac1+/2pat. placenta and in several tissues from P1
Zac1+/2pat. heterozygous offspring (Figure 1D). Further-
more, immunohistochemistry of Zac1+/2pat. retinas
demonstrated a complete loss of Zac1 expression (data
not shown) (L. Ma, N. Klenin, A.V., S. McFarlane, L.J., and
C. Schuurmans, unpublished data). Zac1+/2pat. hetero-
zygous offspring were then likely to behave pheno-
typically like homozygous offspring.
Intrauterine Growth Restriction in Mice Lacking Zac1
We compared the body weight at birth for all four possi-
ble genotypes. As expected for a maternally repressed
gene, Zac1+/2mat. heterozygotes were indistinguishable
from wild-type pups, whereas Zac1+/2pat. pups dis-
played a weight reduction that was also observed in
Zac12/2 homozygotes (Figure 2A). Wild-type and homo-
zygous Zac12/2males were mated to wild-type females,
and offspring was weighed at E13.5, E16.5, E18.5, and
P0. Heterozygous Zac1+/2pat. mice displayed a highly
significant reduction in body weight from E16.5 on
(Figure 2B). The overall weight loss was 11% at E16.5
and 23% at birth, but was not similar for every organ.
At E18.5, Zac1+/2pat. hind limb weight was reduced pro-
portionally to the whole embryo body weight (Figure 2C),
whereas the Zac1+/2pat. brain displayed no absolute
weight change and was consequently larger relative
to the embryo body weight. The reverse was observed
for Zac1+/2pat. liver and lung whose weights were
more strikingly reduced relative to the body weight of
Zac1+/2pat. embryos (Figure 2C).
Because intrauterine growth restriction may result
from impaired placental function, we assessed the func-
tional status of wild-type and Zac1+/2pat. placentas.
Loss of Zac1 function minimally affects placental weight
bands, despite the fact that the antiserum recognizes a region of
the protein not disrupted in the knockout allele.
(D) Expression of Zac1 in P1 tissues and E18.5 placentas was as-
sessed by real-time RT-PCR. No Zac1+/2pat. tissue exhibited Zac1
expression, except the pituitary gland, which showed a very faint
Zac1 signal, i.e., 1.1% of the wild-type signal. Data are mean 6 SD
of three independent reverse transcription reactions.
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713and does not significantly alter either placental histology
or transport capacity of glucose and amino acids (see
the Supplemental Results and Figure S1 in the Supple-
mental Data available with this article online).
Loss of Zac1 Function Results in Altered Gross
Morphology and Bone Formation
In addition to the consistently observed reduced weight,
one third of Zac1+/2pat. pups displayed a severely
altered gross morphology, including a curly tail and
wrinkled skin (Figure 3A). Because Zac1 is abundantly
expressed in somites (Piras et al., 2000; Valente and
Auladell, 2001) and chondrogenic tissues (Tsuda et al.,
2004), we paid special attention to muscle and bone
formation. We performed bone and cartilage staining
on E18.5 embryos and evidenced altered ossification
of the most caudal vertebrae, ankle bones (Figure 3B),
and the last forelimb phalanx (Figure 3C).
Figure 2. Intrauterine Growth Restriction in Mice Lacking Zac1
(A) Wild-type P0 pups (n = 188) were obtained by mating wild-type
males and females. Zac1+/2mat. P0 pups (n = 25) were obtained by
mating wild-type males to homozygous females. Zac1+/2pat. P0
pups (n = 231) were obtained by mating homozygous males to
wild-type females. Zac12/2 P0 pups (n = 17) were obtained by mat-
ing homozygous males and females. The P0 pups were weighed
immediately after birth, and the observed differences were tested
using a Student’s t test (triple asterisk, p < 0.001). Data are
mean 6 SD of the indicated number of animals.
(B) Wild-type or Zac12/2 males were mated to wild-type females to
produce wild-type or Zac1+/2pat. embryos and pups. Offspring were
weighed at E13.5 (+/+, n = 56; +/2pat., n = 31), E16.5 (+/+, n = 46;
+/2pat., n = 43), E18.5 (+/+, n = 76; +/2pat., n = 69), and P0 (+/+,
n = 96; +/2pat., n = 90). Data are mean6 SD of the indicated number
of animals.
(C) E18.5 embryos were dissected, and organs were weighed: brain
(+/+, n = 22; +/2pat., n = 24), liver (+/+, n = 59; +/2pat., n = 61), hin-
dlimb (+/+, n = 54; +/2pat., n = 61), lung (+/+, n = 33; +/2pat., n = 34).
Where indicated, the weight of the different organs was normalized
to the weight of the corresponding embryo (double asterisk, p <
0.01). Data are mean 6 SD of the indicated number of animals.Impaired Postnatal Survival of Zac1+/2pat. Mice
Animals were routinely genotyped at 3 weeks postnatal,
and we noticed that the transmission of the mutation
was not Mendelian when of paternal origin. Mating of
wild-type males to heterozygous females resulted in
roughly equivalent numbers of wild-type and heterozy-
gous pups (Figure 4A) (n = 302). In sharp contrast, mat-
ing of heterozygous males to wild-type females resulted
in a drastically lower than expected number of hetero-
zygous pups (Figure 4A) (n = 774). About 80% of the ex-
pected heterozygous pups were indeed missing. Mating
of heterozygous males and females also resulted in
Figure 3. Lack of Zac1 Alters Embryonic Development
(A) Wild-type and Zac1+/2pat. heterozygous pups were photo-
graphed at birth. The morphological defects of the Zac1+/2pat.
pup, i.e., curled tail and wrinkled skin, were observed in one third
of Zac1+/2pat. pups.
(B and C) Cartilage and bone of E18.5 wild-type and Zac1+/2pat.
heterozygous embryos were stained with alcian blue and alizarin
red. Consistent observations include ossification defects of the
most caudal vertebrae, bones of the ankle, and last phalanx of the
forelimb.
Developmental Cell
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(A) Wild-type C57BL/6 males were mated to C57BL/6 heterozygous
females to produce wild-type and Zac1+/2mat. pups (n = 302). Het-
erozygous males were mated to wild-type females to produce
wild-type and Zac1+/2pat. pups (n = 774). Heterozygous males and
females were mated to produce all possible genotypes (n = 320).
Pups were genotyped at 3 weeks postnatal, and the number of
wild-type, heterozygous, and homozygous pups was expressed
relative to the number of wild-type pups.
(B) Zac1+/2pat. pups die within 3 days post-natal. C57BL/6 wild-type
and homozygous males were mated to C57BL/6 wild-type females to
produce wild-type (n = 61) and Zac1+/2pat. heterozygous (n = 113)
pups. Pups were monitored every 8 hr for the first 24 hr and then
every day until weaning (P21).
(C) The same experiment as the one described in Figure 4A was per-
formed with wild-type and heterozygous CBA mice. Wild-type CBA
males were mated to heterozygous CBA females to produce wild-
type and Zac1+/2mat. pups (n = 290). Heterozygous CBA males
were mated to wild-type CBA females to produce wild-type and
Zac1+/2pat. pups (n = 202).reduced number of homozygous and heterozygous
pups (Figure 4A) (n = 320).
We genotyped new born pups and embryos at differ-
ent stages and found equal numbers of wild-type and
heterozygous offspring from wild-type females mated
to heterozygous males (data not shown). We concluded
that the observed death occurred postnatally. We scru-
tinized newborn pups and noticed that many Zac1+/2pat.
pups displayed dyspnea. Accordingly, about 50% died
within 24 hr after birth, and an additional 20% died be-
fore postnatal day 3 (P3) (Figure 4B). We dissected
and fixed lungs from a number of pups just after they
died and observed that the lungs were either not or im-
perfectly inflated (data not shown). None of the pups with
obvious malformation(s) survived more than 3 days. In
addition, some morphologically normal pups also died.
All pups that survived until P3 reached adulthood
(Figure 4B).
Because all animals observed so far had a C57BL/6
genetic background, we asked whether the observed
postnatal death was specific to this background. We
performed similar experiments in a CBA background
and also observed postnatal lethality of Zac1+/2pat.
pups (Figure 4C). The extent of lethality was however
reduced, suggesting that the effect of loss of Zac1 func-
tion is modulated by genetic background.
Zac1 Belongs to a Network of Imprinted Genes that
Regulate Embryonic Growth and Differentiation
To gain insights into Zac1 mechanism of action, we
searched for genes frequently coexpressed with Zac1.
One of us (P.P.) recently reported a meta-analysis of a
large set of human microarray data (Lee et al., 2004a).
A similar study was performed on a body of 116 mouse
microarray data sets, each data set containing 10
to >200 different samples. These data are freely acces-
sible at http://microarray.genomecenter.columbia.edu/
cgi-bin/find-links.cgi. We looked for genes coregulated
with Zac1/Plagl1 in this large set of microarray data
and recorded the strength of each coexpression link
(Lee et al., 2004a), i.e., the number of data sets in which
Zac1 was significantly coregulated with a given gene.
We noticed that Zac1 was frequently linked to other im-
printed genes with a strengthR 2. Indeed, of 353 genes
retrieved this way, 13 are imprinted, i.e., Gtl2/AI852838
(strength = 7), H19/X58196 (6), Mest (6), Dlk1 (4), Peg3
(4), Grb10 (3), Igf2 (3), Igf2r (3), Dcn (2), Gnas (2), Gatm
(2), Ndn (2), Slc38a4 (2). Since 34,018 mouse genes/
ESTs, of which 60 are imprinted, were tested in at least
two datasets, we computed a p value by using the bino-
mial approximation to the hypergeometric distribution
and worked out p < 8 3 10215. We conclude that the
clustering of Zac1 with other imprinted genes in this
type of analysis is highly significant. Accordingly, we hy-
pothesized that Zac1might work together with other im-
printed genes, prompting us to undertake a systematic
search for genes linked to every imprinted gene with
a strengthR 2. To focus on the genes most tightly linked
to imprinted genes, we selected the 246 genes linked to
at least three different imprinted genes with at least one
link with a strengthR 4. To make the resulting network
more accessible and easier to visualize, we only drew on
Figure 5 the 442 links with a strengthR 4. The full list of
genes and links is available as Supplemental Data. It
Networking among Imprinted Genes
715Figure 5. Zac1 Belongs to a Network of Coregulated Imprinted Genes
Genes linked to imprinted genes, including Zac1, were searched for in a body of 116 microarray data sets, each comprising a minimum of ten
samples. To facilitate the visualization of the resulting gene network, we selected the 246 genes linked to at least three imprinted genes and draw
the 442 links with a strengthR 4 with Pajek software. The links between genes have different gray densities according to the number of data sets
in which the genes are coregulated (light gray = 4 to black = 10).should be emphasized that genes linked to only one
imprinted gene on Figure 5 are in fact linked to at least
two additional ones. For instance, although Birc5 is
apparently linked to only one imprinted gene (Gatm;
strength = 4) on Figure 5, it is indeed connected to five
additional ones (Zac1, Peg3, Mest, Ndn, Gtl2) with a
strength < 4.
Zac1 Misexpression Alters the Expression
of Several Imprinted Genes
To substantiate the affiliation of Zac1 to the imprinted
gene network (IGN) described above, we tested whether
gain and loss of Zac1 function alter the expression of
genes comprised in this network. We focused on im-
printed genes and designed and validated primers to
perform real-time PCR for the 15 imprinted genes com-
prised in the IGN. Although Slc38a4 is not represented
on Figure 5 because it does not fulfill the criteria used
to draw this network, it was included in the analysis be-
cause it is linked to Zac1 as mentioned above and to
other nonimprinted genes within the IGN (see the Sup-
plemental Data). We used three primer pairs for the
Gnas locus, i.e., Gnas exon1, Gnas exon1A, Gnas XL,
because this complex locus includes three alternative
promoters that give rise to transcripts encoding at least
two different proteins (Plagge et al., 2004).
We first used a transient transfection paradigm and
selected the Neuro2a neuroblastoma cell line, which isderived from postganglionic sympathetic neuroblasts
that normally express Zac1 during development (Piras
et al., 2000), and lost Zac1 expression upon transforma-
tion (Table 1). We achieved R95% transfection effi-
ciency, and we verified that the level of Zac1 expression
following transfection is comparable to that measured in
native tissues, e.g., embryonic and neonate brain, pitui-
tary gland, tongue, hindlimb (data not shown). We com-
pared the expression levels of imprinted genes 32 hr
after transfection with cDNAs encoding chlorampheni-
col acetyl-transferase (CAT) as a control or Zac1. Using
this strategy, we showed that Zac1 re-expression in
Neuro2a cells leads to the induction of several imprinted
genes, notably Igf2 (2003), Cdkn1c (163), H19 (113),
and Dlk1 (1.83) (Table 1). These changes in gene ex-
pression were unlikely to result from a proliferation shut-
down or from the induction of apoptosis since they were
also observed, with a lower magnitude, 10 hr following
transfection, when neither growth arrest nor apoptosis
is observed (data not shown).
We then tested whether changes in imprinted gene
expression also occur following loss of Zac1 function
and performed a similar real-time PCR analysis of wild-
type and Zac1+/2pat. E18.5 liver. We verified that the cell
composition of mutant livers was not affected as this
may complicate the interpretation of the observed
regulations (Supplemental Results and Figure S2). Real-
time PCR analysis revealed a statistically significant
Developmental Cell
716Table 1. Gain and Loss of Zac1 Function Elicit Opposite Regulation of Cdkn1c, Igf2, H19, and Dlk1
Neuro2a Liver
Gene Name CAT SD Zac1 SD Zac1/CAT p< +/+ SD +/2pat. SD +/2pat./+/+ p<
Cdkn1c/Kip2 0.012 0.004 0.191 0.013 16.13 0.001 11.977 1.856 6.471 1.226 0.54 0.001
Dcn 0.003 0.002 0.008 0.001 — 1.389 0.097 1.689 0.096 1.22 0.001
Dlk1/Pref1 0.640 0.027 1.139 0.032 1.78 0.001 6.767 0.395 5.195 0.488 0.77 0.001
Gatm 0.000 0.000 0.000 0.000 — 0.390 0.016 0.369 0.028 0.95 NS
Gnas exon1 10.03 1.933 14.514 2.333 1.45 NS 0.522 0.057 0.596 0.107 1.14 NS
Gnas exon1A 0.143 0.047 0.252 0.045 1.77 NS 0.004 0.002 0.006 0.002 1.36 NS
Gnas XL 0.657 0.102 1.606 0.565 2.45 NS 0.041 0.008 0.059 0.008 1.42 0.010
Grb10 0.003 0.002 0.000 0.000 — 12.694 0.749 9.845 0.911 0.78 0.001
Gtl2 0.020 0.003 0.080 0.010 4.11 0.001 5.764 0.173 5.199 0.519 0.90 NS
H19 0.005 0.001 0.056 0.006 10.92 0.001 515.011 57.420 424.644 24.831 0.82 0.010
Igf2 0.002 0.001 0.368 0.034 199.58 0.001 98.463 11.412 72.216 7.149 0.73 0.001
Igf2r 0.001 0.001 0.003 0.001 — 0.749 0.081 0.661 0.059 0.88 NS
Mest 12.80 2.009 19.398 0.461 1.52 0.010 2.937 0.204 3.459 0.215 1.18 0.010
Ndn 0.000 0.000 0.000 0.000 — 0.096 0.004 0.093 0.018 0.97 NS
Peg3 1.270 0.178 1.550 0.145 1.22 NS 1.531 0.116 1.529 0.092 1.00 NS
Sgce 0.658 0.111 0.670 0.029 1.02 NS 0.486 0.066 0.481 0.034 0.99 NS
Slc38a4 0.001 0.001 0.002 0.001 — 2.658 0.124 2.538 0.179 0.95 NS
Zac1 0.000 0.001 0.001 0.000 — 1.511 0.034 0.000 0.000 —
Neuro2a cells were transiently transfected with chloramphenicol acetyltransferase (CAT) or Zac1. Total RNA from three independent transfec-
tions was used to generate cDNAs in three independent reverse-transcription reactions. Liver was dissected from E18.5 wild-type (+/+) and
Zac1-deficient (+/2pat.) embryos. Total RNA from 12 embryos of each genotype from two independent litters was pooled and reverse tran-
scribed in three independent reactions to produce cDNAs. Imprinted gene expression levels were determined in duplicate in each cDNA prep-
aration by real-time PCR. Expression levels of each imprinted gene was normalized to that of three housekeeping genes. Average of normalized
expression levels (CAT; Zac1; +/+; +/2pat.), standard deviation (SD), ratio (Zac1/CAT; +/2pat. / +/+), and p value (Student’s t test) are displayed
for each imprinted gene. Primers used to quantify Zac1 in Neuro2a cells are located in the 30UTR and do not detect the transfected Zac1 cDNA.
Primers to quantify Zac1 expression in E18.5 liver are located in the coding region that was deleted by homologous recombination. Ratios and
p values in bold denote significantly differentially expressed genes. Values in italics correspond to genes called absent. NS, not significant.downregulation of the imprinted genes that were found
upregulated in Zac1-transfected Neuro2a cells, i.e.,
Igf2 (1.43), Cdkn1c (1.93), H19 (1.23), and Dlk1 (1.33)
(Table 1).
Zac1 Binds to H19 30 Enhancers, which Results in
Transactivation of Igf2 and H19 Promoters
Given the phenotype of the Igf2-, H19-, Cdkn1c-, and
Dlk1-deficient mice, the downregulation of these genes
in Zac1-deficient liver possibly accounts for the growth
restriction phenotype of Zac1-deficient mice. We hence
tested whether Zac1 is a direct regulator of these genes.
We focused on Igf2 and H19 because the genes are ad-
jacent on mouse chromosome 7 but are expressed from
the paternal and maternal chromosome, respectively.
Zac1 could then independently regulate each gene
through binding to their respective promoters; alterna-
tively, Zac1 could bind to a shared regulatory element.
We noticed that the H19 locus comprises several Zac1
consensus binding sites (G4C4) (Figure 6A) (Hoffmann
et al., 2003; Varrault et al., 1998), notably in each of the
two endodermal enhancers located 30 of H19 (Leighton
et al., 1995). We performed chromatin immunoprecipi-
tation on Zac1-transfected Neuro2a and MIN6 cells
(Figure 6B). For Neuro2a cells, three independent chro-
matin preparations were made, immunoprecipitated in
duplicate, and quantified in duplicate. For MIN6 cells,
nine independent chromatin preparations were made,
immunoprecipitated, and quantified in duplicate. To as-
sess for the statistical significance of the observed dif-
ferences, we performed a one-sided, paired permuta-
tion test with exact statistics. No Zac1 binding was
observed in the Igf2 gene (data not shown). We showedsignificant binding of Zac1 to theH19 enhancer region in
both cell lines and a weaker binding to theH19 promoter
in MIN6 cells (Figure 6B).
To test for the functional correlate of Zac1 binding, we
constructed plasmids containing the Luciferase cDNA
as a reporter gene (Figures 6C and 6D). Luciferase was
flanked on the 50 side by either a minimal TATA box de-
rived from the adenoviral E1B promoter, the H19 pro-
moter, or the P3 Igf2 promoter. It was flanked down-
stream of the polyadenylation site by either no specific
sequence or the H19 enhancers, alone or in combina-
tion. We transfected these constructs together with
cDNAs encoding chloramphenicol acetyl-transferase
(CAT) as a control or Zac1 in HepG2 hepatocarcinoma
cells, in which the H19 enhancers were previously
shown to work in reporter assays (Long and Spear,
2004; Yoo-Warren et al., 1988). Eight independent trans-
fections with two different plasmid preparations were
carried out. To assess for statistical significance of the
observed differences, we performed a two-sided, paired
permutation test with exact statistics. As expected, the
enhancers were active on the H19 (Figure 6C) and Igf2
P3 (Figure 6D) promoters but not on the minimal E1B
TATA box (data not shown). Remarkably, Zac1 potenti-
ated the effect of the E2 enhancer on both promoters
(Figures 6C and 6D). Because we detected a weak
Zac1 binding to the H19 promoter in MIN6 cells, we
also tested for transactivation of this promoter in these
cells. We observed a significant 2.1-fold stimulation of
the luciferase activity following Zac1 transfection (data
not shown). The effect of Zac1 on H19 enhancers could,
however, not be tested in this cell line because the en-
hancers showed no effect per se on either the H19 or
Networking among Imprinted Genes
717Figure 6. Zac1 Binds to the Endodermal En-
hancers Downstream of H19 and Transacti-
vates H19 and Igf2 Promoters
(A) Simplified map of the H19 locus. DMD de-
notes the intergenic differentially methylated
region between Igf2 and H19. G4C4 denotes
Zac1 consensus binding sites (Hoffmann
et al., 2003; Varrault et al., 1998). Closed ovals
indicate the location of endodermal en-
hancers.
(B) Real-time PCR scan of the H19 locus fol-
lowing chromatin immunoprecipitation.
MIN6 and Neuro2a cells were transfected
with a plasmid encoding Zac1. Chromatin im-
munoprecipitation with anti-Zac1 and preim-
mune sera was performed as described in
the Experimental Procedures. The amount of
immunoprecipitated material was quantified
by real-time PCR with primers located
throughout theH19 locus. The relative enrich-
ment fold (anti-Zac1/preimmune) is plotted
against the position of the primer pair used
for real-time PCR on contig AF049091. Data
are mean 6 SEM of six (Neuro2a) or nine
(MIN6) independent immunoprecipitations.
p values were computed with exact statistics
in a one-sided, paired permutation test (aster-
isk, p < 0.05; double asterisk, p < 0.01).
(C) Zac1 binding to the E2 enhancer regulates
the activity of the H19 promoter. A minimal
TATA box from the adenovirus E1B promoter
or a PCR fragment comprising 440 bp from
the H19 promoter was subcloned upstream
of the Luciferase cDNA. PCR fragments con-
taining the H19 E1 and E2 enhancers were
subcloned downstream of the SV40 polyade-
nylation site. The reporter plasmids were
transfected into hepatocarcinoma HepG2
cells together with plasmids encoding CAT or Zac1. Data are mean 6 SEM of eight independent transfections quantified in triplicate. p values
were computed with exact statistics in a two-sided, paired permutation test (asterisk, p < 0.05; double asterisk, p < 0.01).
(D) Zac1 binding to the E2 enhancer regulates the activity of the Igf2P3 promoter. Same as in (C) with a 760 bp fragment from the Igf2P3 promoter.
(E) Zac1 binds to theH19 30 E2 enhancer, and mutation of the G4C4 Zac1 consensus binding site abolishes Zac1 binding. Electrophoretic mobility
shift assay (EMSA) was performed with nuclear extracts from GFP- and Zac1-transfected Neuro2a cells as described in the Experimental Proce-
dures. The specificity of the binding is demonstrated by competition with a 10-fold excess of the cold probe (cold E2) or of the cold mutated probe
(cold E2mut) and incubation with the anti-Zac1 antibody resulting in supershift of the E2 probe.
(F) Same as in (C) with a wild-type or a mutated Zac1 binding site in the E2 enhancer. Data are mean6 SD of four independent transfections quan-
tified in triplicate. p values were computed with exact statistics in a two-sided, paired permutation test (double asterisk, p < 0.01).
(G) Same as in (F) with a 760 bp fragment from the Igf2 P3 promoter.the Igf2 P3 promoter, as previously reported in other cell
lines (Yoo-Warren et al., 1988).
Zac1 Potentiates E2 Activity through Binding to Its
Consensus Binding Site
To further characterize the regulation of the E2 enhancer
activity by Zac1, we assessed the direct binding of Zac1
to E2. We performed EMSA with an oligonucleotide lo-
cated in the E2 region and comprising the Zac1 consen-
sus binding site (G4C4). We showed that nuclear extracts
from Zac1-transfected Neuro2a cells shift the oligo,
whereas those prepared from GFP-transfected cells
do not (Figure 6E). Furthermore, mutation of the G4C4
sequence to G3ATC3 abolished Zac1 binding (Figure 6E).
The specificity of Zac1 binding was further demon-
strated by competition with a 10-fold excess of cold
wild-type or mutated E2 probes and by supershifting
with the anti-Zac1 antibody. We introduced a similar
mutation in the plasmids used in Figures 6C and 6D
and verified that abolition of Zac1 binding to its consen-sus site in the E2 region alters its functional activity (Fig-
ures 6F and 6G). The potentiation by Zac1 of E2 activity
toward the H19 promoter was drastically reduced
(Figure 6F), indicating that Zac1 binding to its consensus
binding site within E2 is required for its full activity and
that Zac1 also works through another interaction with
E2. This interaction could be direct through binding to
a cryptic site in E2; it could also be indirect since Zac1
was shown to work as a coactivator of other transcrip-
tion factors such as nuclear receptors (Huang and Stall-
cup, 2000) and p53 (Huang et al., 2001; Rozenfeld-
Granot et al., 2002). The effect of the mutation on the
Igf2-P3 promoter was even more drastic as Zac1 was not
able to potentiate the effect of mutated E2 toward this
promoter (Figure 6G). Indeed, mutation of Zac1 consen-
sus binding site within E2 fully abolished its enhancer
activity (Figure 6G), suggesting that this sequence is
absolutely required for E2 activity toward Igf2-P3.
Altogether, these data indicate that Zac1 robustly binds
to the H19 30 E2 enhancer, which results in transactiva-
tion of the H19 and Igf2 promoters.
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The present report demonstrates that Zac1 belongs to
the class of imprinted genes involved in embryonic
growth control since loss of Zac1 function resulted in
intrauterine growth restriction. This observation was
made in offspring from wild-type females mated to ho-
mozygous males, which implies that growth restriction
does not result from a shortcoming of the mother or
from competition between embryos of different geno-
types. It is therefore concluded that the growth defect
is intrinsic to the conceptus. Intrauterine growth restric-
tion potentially results from an intrinsically defective
growth of the embryo and/or an impaired transport
of nutrients across the placenta (Reik et al., 2003).
Although Zac1 is expressed in the placenta, the placen-
tal function was not affected in Zac1 mutant mice (Sup-
plemental Data), which is in favor of a direct effect of
Zac1 on embryonic growth.
The embryonic growth restriction phenotype ob-
served in Zac1-deficient mice is counterintuitive. In-
deed, it is generally observed that inactivation of genes
promoting cell proliferation, e.g., oncogenes, leads to
growth restriction, and inactivation of genes restraining
cell proliferation, e.g., tumor suppressor genes, leads
to overgrowth (Ciemerych and Sicinski, 2005). For in-
stance, the inactivation of Igf2 induces intrauterine
growth restriction (DeChiara et al., 1990), and the inacti-
vation of Igf2r (Wang et al., 1994) results in embryonic
overgrowth. It was therefore unexpected that the inacti-
vation of Zac1, a putative tumor suppressor gene with
proapoptotic and cell-cycle-blocking activities, results
in embryonic growth restriction. On the other hand, the
kinship theory predicts that paternally expressed im-
printed genes are growth promoting, and maternally
expressed genes are growth restraining. The growth re-
striction phenotype of Zac1-deficient embryos shows
that Zac1 complies with the kinship theory and accounts
for the paternal expression of this antiproliferative gene.
Therefore, evolution selected a limited number of genes
to be imprinted according to their physiological proper-
ties rather than their molecular functions.
To gain insights into Zac1 mechanism of action, we
used the results of a meta-analysis of 116 microarray
data sets and searched for genes frequently coregu-
lated with Zac1. The underlying assumption is that
genes that cluster together would share biological func-
tion (Fraser and Marcotte, 2004). This approach proved
extremely informative in relatively simple model organ-
isms such as yeast (Lee et al., 2004b; Wu et al., 2002)
and C. elegans (Kim et al., 2001) but is still not widely
used for mammals (Lee et al., 2004a; Zhang et al.,
2004). We noticed that the set of genes most closely
linked to Zac1 displayed a statistically highly significant
overrepresentation of imprinted genes, i.e., Gtl2, H19,
Mest, Dlk1, Peg3, Grb10, Igf2, Igf2r, Dcn, Gnas, Gatm,
Ndn, Slc38a4. We made a more systematic search for
genes linked to imprinted genes and focused on the net-
work of imprinted and nonimprinted genes that were the
most densely connected. Because of the phenotype of
Zac1 null mice, and because mutants of numerous other
imprinted genes in this network also display alterations
in embryonic development, we conclude that Zac1 is
a member of an imprinted genes network (IGN) that con-trols embryonic growth and differentiation. This obser-
vation is certainly of interest to understand Zac1 biol-
ogy. It is also relevant in the context of imprinting in
general. Indeed, the IGN we describe in this report may
well be the network of genes involved in the control of
embryonic growth that was supposedly targeted by im-
printing during mammalian evolution (Reik and Lewis,
2005). Additional experiments will be necessary to test
whether a similar network of coregulated genes existed
before the emergence of imprinting during mammalian
evolution.
A general feature of gene networks is to adapt to ge-
netic and environmental changes by altering the expres-
sion of genes they consist of. This is the origin of robust-
ness against mutations during development (Siegal and
Bergman, 2002; Wagner, 2000) and frequently underlies
epistasis (Moore, 2005; Segre et al., 2005). To confirm
that Zac1 belongs to the IGN, we tested whether this
network is transcriptionally perturbed by Zac1 misex-
pression. We first analyzed transiently transfected cells
because this experimental setting provides an opportu-
nity to look at the acute transcriptional response to
Zac1. We observed a large induction of Igf2, Cdkn1c,
and H19 and a moderate but statistically significant
induction of Gtl2, Dlk1, and Mest. We then performed
a similar analysis of E18.5 wild-type and Zac1-deficient
liver. In this setting, the gene network is given time to
adapt to loss of Zac1 function and is supposed to reach
a novel stable state compatible with an almost normal
embryonic development. We observed a significant
downregulation of some of the genes, i.e., Cdkn1c,
Igf2, H19, and Dlk1, which were vigorously induced by
Zac1 re-expression in Neuro2a cells. Another strong ar-
gument in favor of the existence of the IGN, and Zac1’s
affiliation to it, is the demonstration of a direct functional
link between Zac1 and other imprinted genes. Arima and
coworkers recently suggested that human ZAC regu-
lates the expression of CDKN1C through binding to the
CpG island and upregulation of LIT1/KCNQ1OT1, an
antisense imprinted gene thought to negatively regulate
CDKN1C (Arima et al., 2005). Though we could not con-
firm the regulation of mouse Lit1 by Zac1 in real-time
PCR experiments (data not shown), we observed that
deregulated Zac1 expression does alterCdkn1c expres-
sion. In the present report, we focused on Igf2 and H19
because they are adjacent on mouse chromosome 7
and are reciprocally imprinted. We showed that Zac1
binds to and regulates the activity of the E2 enhancer lo-
cated downstream ofH19 and shared with Igf2. Zac1, as
well as FoxA that was recently showed to bind the E1 en-
hancer (Long and Spear, 2004), therefore participates
into the regulation of the Igf2/H19 locus. Zac1 could be
involved in the remodeling of the complex architecture
of this locus (Murrell et al., 2004) and/or could work as
a transcriptional activator or coactivator once the ap-
propriate chromatin loops are formed since both activi-
ties were associated with Zac1 (Hoffmann et al., 2003;
Huang and Stallcup, 2000). Whatever the mechanistic
details are, we showed that Zac1 is upstream of Igf2/
H19, Cdkn1c, and Dlk1 in a genetic network aimed at
controlling embryonic growth.
Deregulation of these genes in Zac1-deficient
mice is likely to account for the observed growth-
restriction phenotype. Indeed, Igf2 (DeChiara et al.,
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Pref1 (Moon et al., 2002) knockout mice display growth
restriction. The extent of Igf2 deregulation in Zac1-
deficient liver is limited (w25%–30%), but it should be
emphasized that complete loss of Igf2 expression in
knockout mice resulted in 40% reduction of body weight
at birth (DeChiara et al., 1990), while Zac1 deficiency re-
sults in 23% body weight reduction. Furthermore, the
concomitant downregulation of several growth-promot-
ing imprinted genes within the IGN, i.e., Igf2, Cdkn1c,
and Dlk1, is likely to have additive effects and to result
in major defect of the biological function conveyed by
this network. It is also noteworthy that the growth-re-
straining imprinted gene Grb10 is downregulated in
Zac1-deficient liver.Grb10 inactivation results in embry-
onic overgrowth, which is partially compensated by Igf2
inactivation (Charalambous et al., 2003). The observed
Grb10 downregulation in Zac1-deficient mice likely cor-
responds to a homeostatic regulation of the IGN aimed
at antagonizing Zac1 deficiency and Igf2, Cdkn1c, and
Dlk1 downregulation. This observation further illustrates
the mechanisms at work to safeguard the robustness of
gene networks and of their associated biological func-
tion(s). Collectively, our data show that Zac1 is a bona
fide member of the IGN and suggest thatZac1deficiency
affects embryonic growth through the deregulation of
other imprinted genes, namely Igf2, Cdkn1c, and Dlk1.
Imprinted genes within the IGN have a pattern of con-
nectivity that is reminiscent of scale-free networks (Bar-
abasi and Albert, 1999).Peg3,Ndn,Gnas, andGatm cor-
respond to hub-like nodes, i.e., they are connected to
a large number of genes. On the other hand, Igf2, Igf2r,
H19, Sgce, Cdkn1c, Grb10, Zac1, Gtl2, Dlk1, and Mest
have a lower degree of connectivity. Additional work
will be necessary to determine if the latter class of im-
printed genes represents the input and regulatory core
of the network, while genes of the hub-like class ensure
the connection to effector genes. The meta-analysis of
microarray data also raises new hypotheses with re-
spect to the biochemical processes controlled by Zac1
and by other imprinted genes. It is worth mentioning
that genes that encode extracellular matrix (ECM) pro-
teins are overrepresented in the IGN. Because the data
sets in which imprinted genes were most frequently
coexpressed correspond to regenerating and develop-
ing muscle (data not shown), an attractive hypothesis
is that the biological function associated with the IGN
is the control of cell adhesion-related processes during
embryonic muscle development.
A recent study suggests that the IGN may also consti-
tute a key safeguard against neoplasm formation in
adults. Holm and coworkers (Holm et al., 2005) showed
that global loss of imprinting (LOI), resulting from tar-
geted inactivation of Dnmt1 in ES cells, most notably af-
fects expression of Zac1 (2.23), Peg3 (1.83), Sgce
(1.63), Ndn (1.63), Igf2r (0.43), Cdkn1c (0.33), and
Grb10 (0.13), which all belong to the IGN. Interestingly,
among the very few nonimprinted genes differentially
expressed in imprint-free versus control MEFs are found
several genes that belong to the IGN, i.e., Matn2, Itm2a,
6330403K07Rik, Col18a1, and Dnmt3a. The result of the
global LOI was the immortalization of embryonic fibro-
blasts and the formation of hepatocellular carcinomas
and intestinal adenomas. In this study, the methylationstatus of the Igf2/H19 locus was variably affected, but
other studies previously demonstrated the importance
of Igf2 LOI in tumor formation (Ohlsson, 2004). Alto-
gether, these data indicate that, in addition to its effect
during embryonic development, alteration of the bio-
chemical process(es) controlled by the IGN is sufficient
to initiate tumor formation and sustain tumor develop-
ment in adults.
Experimental Procedures
Generation and Genotyping of Zac1-Deficient Mice
Two overlapping clones, C26 and C35 comprising the two last exons
of mouse Zac1, were obtained by screening a 129/Sv genomic li-
brary (a generous gift by Dr. Philippe Soriano, FHCRC, Seattle) con-
structed in lDashII (Stratagene). The targeting vector was made by
successive subcloning into pBSII-SK(-) of (1) a 2.5 kbNot I/Pst I frag-
ment from clone C35, corresponding to a portion of the intron 50 of
the first coding exon of Zac1 and a small portion of the lDashII vec-
tor, (2) a Xho I/Hind III fragment containing the pPolII promoter and
the Neo resistance gene, (3) a 5.5 kb Ava I fragment from clone C26
corresponding to most of the last exon of Zac1 and a small portion of
the lDashII vector, and (4) a Sal I fragment containing the thymidine
kinase cassette. The targeting vector (50 mg) was linearized with Not
I and electroporated into 93 106 H1 ES cells (a gift by Drs. A. Dierich
and P. Chambon, IGBMC, Strasbourg). ES cells were plated onto mi-
tomycin C-treated fibroblasts and selected with G418 (180 mg/ml)
and gancyclovir (2 mM) for 2 weeks. One hundred and sixty-one
double resistant clones were expanded and screened by Southern
blotting of KpnI-digested genomic DNA with appropriate PCR frag-
ments as 50 and 30 probes. Homologous recombination resulted in
a size shift from 8.0 to 12.8 kb. Five positive clones were confirmed
by PCR with primers KOZ-i1, KOZ-5nc, and KOZ-pPOL (Table S1).
Cells from five positive clones were injected into C57BL/6 blasto-
cysts and implanted into pseudopregnant females. Chimeric off-
spring were bred to C57BL/6 mice (Charles River France) to produce
Zac1+/2 offspring that were bred to C57BL/6 mice for nine additional
generations. Genotyping was routinely performed with Taqman
probes and primers specific for the wild-type (Zac-2406T; Zac-
2382F; Zac-2449R) and knockout (KOpA-1605T; KopA-1582F;
KopA-1643R) alleles (Table S1).
Skeletal Staining
E18.5 embryos were skinned, eviscerated, and fixed overnight in
100% ethanol. They were stained with alcian blue and alizarin red
as previously described (Vivian et al., 2000).
Construction of the Gene Network
Data from 116 mouse microarray experiments containing a minimum
of ten biological samples per experiment were analyzed exactly as in
Lee et al. (2004a). The description of all data sets used in the meta-
analysis is publicly available at http://microarray.genomecenter.
columbia.edu/cgi-bin/datasetInfo.cgi. The genes linked to each
imprinted gene with a strengthR 2, i.e., in at least two independent
experiments, were retrieved. Only those 246 genes linked to at least
three different imprinted genes were considered for the analysis.
The resulting network was visualized with Pajek software (http://
vlado.fmf.uni-lj.si/pub/networks/pajek/). To make the network
easier to visualize, we only drew on Figure 5 the 442 links with
a strengthR 4.
Plasmids, Cell Culture, and Transfection
Plasmids encoding b-galactosidase, chloramphenicol acetyl-trans-
ferase (CAT), and Zac1 were described previously (Spengler et al.,
1997). Neuro2a, a mouse neuroblastoma-derived cell line, HepG2,
a human hepatocarcinoma cell line, and MIN6, a mouse b-pancreatic
cell line, were routinely cultured in DMEM supplemented with fetal
bovine serum and penicillin-streptomycin (Invitrogen). Cells were
transfected with Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions.
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Total RNA was harvested from Neuro2a cells 32 hr after transfection
and from E18.5 wild-type and Zac1+/2pat. liver. We extracted total
RNA from tissues or cells with Trizol reagent (Invitrogen) according
to the manufacturer’s instructions. We carried out RT-PCR analysis
of total RNA with random hexamer oligonucleotides for reverse
transcription. The sequences of the primers used for the deter-
mination of imprinted gene expression levels are given in Table
S2. The selection of appropriate housekeeping genes was per-
formed with geNorm (Vandesompele et al., 2002). The level of
expression of each imprinted gene X was normalized to the geo-
metric mean of the expression levels of three housekeeping genes
(Hprt, Tbp2, and Tubb2 for Neuro2a cells; B2m, Gus, and Trfr
for E18.5 liver), according to the formula: X/geometric mean (R1,
R2, R3) = 2(Ct[X]2arithmetic mean [Ct(R1),Ct(R2),Ct(R3)]), where Ct is the
threshold cycle, and R1, R2, R3 are the three reference genes.
Chromatin Immunoprecipitation
ChIP was performed by a standard protocol (Kouskouti et al., 2004).
Briefly, MIN6 or Neuro2a cells were fixed in culture medium with 1%
formaldehyde for 10 min at 37C. The cells were then washed in PBS
and lysed in hypotonic buffer. The nuclei were resuspended in
a buffer containing 0.1% SDS. The chromatin was fragmented for
20 min at 4C with a Bioruptor sonicator (Diagerode, Lie`ge, Belgium).
Average length of sonicated fragments was 0.3–0.5 kb for Neuro2A
cells and 0.5–1 kb for MIN6 cells. Diluted chromatin was incubated
overnight with a rabbit preimmune serum or a serum raised against
a GST-Zac1 fusion protein (Spengler et al., 1997). The chromatin was
then collected with protein A-Sepharose beads and extensively
washed. Each immunoprecipitate was assessed by real-time PCR
with primers located in the Igf2/H19 locus or in three control loci
(Blvrb, 5H24, Vgcnl) for normalization. Real-time PCR data were nor-
malized for each immunoprecipitate to the geometric mean of the
PCR signals obtained in the same immunoprecipitate with primers
located in the three unrelated control loci. The sequences of the
primers used for real-time PCR are given in Table S3.
Enhancer Assay
The H19 endodermal enhancers E1 and E2 were PCR amplified with
appropriate primers (Table S4), alone or in combination, and cloned
downstream of the Luciferase/SV40 polydenylation cassette in
pGL2 (Promega). A minimal TATA box from the E1B promoter (Hoff-
mann et al., 2003), a PCR fragment comprising 440 bp from the H19
promoter (see Table S4 for the primer sequences), or a NheI/SacI
fragment containing 760 bp from the Igf2 P3 promoter derived
from pP3L (Caricasole and Ward, 1993) were subsequently cloned
upstream of the Luciferase cDNA. The G4C4 sequence of the E2
enhancer (14,452–14,459 in AF049091) was mutated to G2ATATC2
with QuikChange II XL site-directed mutagenesis kit (Stratagene).
Mutated plasmids were identified by the newly created EcoR V
restriction site. Sequences were verified by sequencing both
strands. Plasmids were transfected into HepG2 hepatoma cells,
and Luciferase and b-galactosidase activity were measured 24 hr
later as previously described (Varrault et al., 2001).
Electrophoretic Mobility Shift Assay
EMSA was performed as previously described (Bilanges et al., 2001).
Briefly, 25-mer oligonucleotides (Table S6) comprising the Zac1
consensus-binding site (G4C4) or a mutated sequence (G3ATC3)
were annealled and labeled with T4 polynucleotide kinase and
32P-gATP. They were incubated with no nuclear extract or nuclear
extracts from GFP- or Zac1-transfected Neuro2a cells. The specific-
ity of the binding is demonstrated by competition with a 10-fold
excess of the cold probe (cold E2) or of the cold mutated probe
(cold E2mut) and incubation with the anti-Zac1 antibody. DNA-
protein complexes were separated from free probe on a 7% poly-
acrylamide gel.
Supplemental Data
Supplemental Data include a detailed analysis of the functional
status of Zac1-deficient placenta (Figure S1), an histological and
microarray characterization of Zac1-deficient liver (Figure S2 and
Supplemental Results), and a list of primers used in this study(Tables S1–S6) and are available at http://www.developmentalcell.
com/cgi/content/full/11/5/711/DC1/.
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